Replies to post #12897 on MMRGlobal, Inc. (fka MMRF)

[investbernie]

Sedge,

I will attempt to field the questions you have presented and I hope my thoughts make sense...

First and foremost, there has been little to no dilution whatsoever at this point in time. Even though the AS was increased months ago, it was primarly done for the sake of how tight the situation was upon conclusion of the reverse merger.

(Options/Warrants/Leverage)

With the increase of the AS, this will allow MMRF "strategic wiggle room" to accomplish their goals, until we achieve profitability.

(I believe Q1 - Q2, 2010)

If management was insensitive to the situation they would have went after using up the entire AS as quickly as possible, and actually they are moving slower than I expected...

(Keep in mind approximately 50M common share potential is owned by Mr. Lorsch & the RHL Group, so heavy dilution hurts his position more than ours.)

As for Dutchess, I believe management did a great job on the negotiations and terms, and in regards to the "big picture" it's a LOC and at most could add 100M to the OS, so very smart and strategic from my point of view.

As for the share price, you have to keep in mind that there were a lot of retail investor's who jumped in to FVRL when it broke below .05 and dropped to .01.

(We made the right move because we didn't believe FVRL would go BK. It touched .01 in the fall, and then again in December 2008 (.011). Once the non-binding was in place on 10/28/09, I was completely convinced we were in the clear and added a shitload of shares at .015 - .02 on the "December insider selling plunge". Tulaz, Warren, Bum, and myself were just a couple of the retailers at the time, and combined we own millions upon millions of shares from this level.)

Basically what I'm saying is there were plenty of retailers gambling on FVRL's survival and they had the opprotunity to build large positions very low.

(Think about it for a second. If I bought 1M @ .015 and sold them today a year later, at .075 would it matter? Sure, I'd be pissed I didn't sell them at .30, but hey, I still made a huge percentage profit off the investment.)

Anyway, besides the MM's playing into the low/weak buying pressure over the past couple months, I have to believe it's a retailer who picked up a ton of shares last year who has been slowly liquidating.

(Also keep in mind HDSN was the MM who absorbed almost all shares being dumped when FVRL went to FVRL.PK then FVRL.OB, then things were finally brought under control when the MMR deal was announced. If I remember correctly the OS was around 42M at the time and I believe about 15M was in strong hands so about 25-30M shares were absorbed, at a very low PPS...)

Futhermore, we are on the verge of something great, and MMRF is going to be huge if we exercise patience. Add in some solid AntiCD-20 value and this baby is a homerun...

Keep in mind Seymour and Longenecker didn't hang around MMRF until June 30th 2009 just for the heck of it, or for their experience in regards to PHR/EMR technology... Ha!

Best Regards, Bernie

[Tulaz1]

Sedge,

Bernie does a great job at explaining ths situation as to why the stock is where it is. Nowadays people don't invest $$ in potential. They have more of a "show me the money" type approach. Last we checked MMR was in debt & although they got the financing they needed, they still have yet to really prove themself. HealthCare in general is all over the place and I don't think investors would feel any more confident in the HealthCare IT sector. All JMHO. The story is not where we are, but more as to where they are going which brings us to .07 - .08 BOD's took over and loaded up shares in January 2009 @ .12 and up. They just signed a deal in China to market all of their products to different parts of the country's healthcare system(MMR Pro/PHR), their financial sector(Esafe), and to scientists and labs(anti-cd20 and possible PHR). After January 2010 this company will be fully completed in "creating the products" and the shift of the focus will be to "sell the products". As of now they have not been doing that. MMR Pro's commercial release is not until January and this product will be in both China and the US.

The UNIS-Tonghe deal is a revenue sharing contract. MMR Pro is a revenue sharing deal with Physicians. MMR is basically giving their profits and sharing them with everyone in hopes that their products can be used by the whole world & even in conjunction with other PHR's and EMR's. Its an everyone wins type situation because at the end of the day I use an MMR PHR and can see the need for electronic storage. Its something I'm suprised the Healthcare sector has taken this long to actually catch on to - that everyone uses computers to make things easier and cut costs. It all starts in the doctor's offices, though. This is the reason the company is where it is now - because we haven't gotten there yet. I could say I saw this coming, but I didn't know MMR Pro would be delayed for a year. The simple sale of one MMR Pro subscription to one doctor could be $300/month with the potential of bringing in 1-20K/month with no additional work on the part of MMR. This is assuming doctors have around 2,000 patients and can sell them PHR upgrades so that they can store ther whole family's health records in one place(pets too). In general a PHR purchaser I'd assume would feel safer buying a PHR from their doctor than from a Costco or Microsoft. Its all in the potential right now until we actually see sales of these products and its kind of hard to not already see alot of green in the future. If I've never heard of Bob Lorsch or anyone else on this team and just knew about these products I would still be very bullish, but just knowing the CEO has been extremely successful in his past and he has surrounded himself with people just like himself - "his friends" leads me to believe we are looking at a rarity here in MMRF.

I'm sick and tired of hearing people put the company down because they look at the stock price. Those who don't feel like spending more than an hour on a company's background shouldn't really even claim they know where the company and the stock price is going to begin with.